In recent years, an increasing number of studies have shown that the expression and regulation of IKBKE is not merely limited to the fields of innate immunity, inflammatory response, and metabolic diseases but that it also extends to the fields of oncogenesis, progression, transformation, and chemotherapeutic resistance of cancers. Here, IKBKE is linked to cancer.